Literature DB >> 20381118

Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study.

Anja C Roden1, Marie-Christine Aubry, Kai Zhang, James O Brady, David Levin, Ahmet Dogan, Eunhee S Yi.   

Abstract

Nodular pulmonary amyloidosis, characterized by solitary or multiple parenchymal nodules, is primarily composed of amyloid immunoglobulin light chain protein. Pulmonary involvement by senile amyloidosis has been reported as an incidental finding with scattered or diffuse interstitial deposition of amyloid protein transthyretin mostly in patients with cardiac senile amyloidosis in a small number of autopsy cases. We report a unique case of pulmonary senile amyloidosis presenting with conglomerated nodular deposition of amyloid protein transthyretin as the main clinical manifestation. The patient was an 82-year-old man who presented with recurrent pleural effusions and nodular replacement of pulmonary parenchyma on a chest computed tomographic scan. He underwent a wedge resection of the lesion. Histologic examination revealed a massive deposition of Congo red-positive amyloid identified as amyloid protein transthyretin by both immunohistochemistry and mass spectrometry using formalin-fixed, paraffin-embedded tissues. Molecular testing did not show any mutation associated with familial amyloidosis in the TTR gene, further supporting the diagnosis of senile amyloidosis. To our knowledge, this is the first documented case of nodular senile amyloidosis of the lung that was confirmed with the current state-of-the-art methods. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381118     DOI: 10.1016/j.humpath.2009.11.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration.

Authors:  Anita D'Souza; Jason D Theis; Julie A Vrana; Ahmet Dogan
Journal:  Amyloid       Date:  2014-01-22       Impact factor: 7.141

2.  MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.

Authors:  Martin Winter; Andreas Tholey; Sandra Krüger; Hartmut Schmidt; Christoph Röcken
Journal:  J Histochem Cytochem       Date:  2015-06-22       Impact factor: 2.479

3.  Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.

Authors:  Peter Mollee; Samuel Boros; Dorothy Loo; Jayde E Ruelcke; Vanessa A Lakis; Kim-Anh Lê Cao; Patricia Renaut; Michelle M Hill
Journal:  Clin Proteomics       Date:  2016-10-27       Impact factor: 3.988

Review 4.  Recent advances in transthyretin amyloidosis therapy.

Authors:  Mitsuharu Ueda; Yukio Ando
Journal:  Transl Neurodegener       Date:  2014-09-13       Impact factor: 8.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.